Related Experiment Video
Updated: Apr 12, 2026
06:01
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
15.7K
Acute ischemic stroke: overview of recent therapeutic developments
Nijasri Suwanwela1, Walter J Koroshetz
1Stroke Service, Chulalongkorn University Hospital, Bangkok, Thailand.
Annual Review of Medicine
|January 16, 2007
Summary
Stroke therapies are evolving rapidly, particularly acute treatments that can reverse deficits. This review highlights emerging stroke treatments focusing on prevention, rehabilitation, and ultra-early interventions to improve patient outcomes and reduce disability.
Area of Science:
- Neurology
- Public Health
- Emergency Medicine
Background:
- Stroke is a global public health crisis requiring comprehensive therapeutic strategies.
- Current efforts focus on prevention, acute treatment, and rehabilitation.
- Significant advancements in acute stroke care have emerged in the last decade.
Purpose of the Study:
- To review emerging and future stroke therapies.
- To highlight recent changes in acute stroke treatment.
- To discuss the impact of new therapies on patient recovery and disability.
Main Methods:
- Literature review of recent advancements in stroke therapy.
- Analysis of emerging ultra-early-stage treatments.
- Comparison with historical trends in cardiovascular emergency care.
Main Results:
- Ultra-early therapies show potential to reverse severe neurologic deficits.
- Acute stroke treatment has undergone significant restructuring.
- Preventative measures offer the greatest public health impact.
Conclusions:
- Emerging stroke therapies are transforming emergency neurological care.
- Focus on ultra-early interventions and rehabilitation is crucial for improving outcomes.
- Preventative strategies remain key to mitigating the global burden of stroke.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.5K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
01:17Ischemic Heart Disease: Overview
4.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.0K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K